News & Media

Latest Press Release

November 14, 2017

BioSig Technologies Adds Role of Chief Regulatory and Compliance Officer in Preparation for FDA Submission

Santa Monica, CA, Nov. 14, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announced that the Company has engaged Tiffini Wittwer as Chief Regulatory and Compliance Officer for the upcoming regulatory clearance of PURE EP(TM) System. Mrs. Wittwer brings to BioSig over 15 years of experience in…

Read More